Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Haihua Life Science Co., Ltd. is a biotechnology subsidiary of the Shandong Haihua Group, focused on the development and production of bio-based materials and food additives. The company utilizes synthetic biology and advanced fermentation technologies to manufacture high-demand products such as erythritol, a zero-calorie sweetener. Based in Weifang, China, it integrates the parent group's extensive chemical manufacturing expertise with modern life science applications. Haihua Life Science aims to serve the global food, beverage, and pharmaceutical industries with sustainable, bio-manufactured ingredients. The company represents a strategic shift for its parent group toward high-value-added green chemistry and the life sciences sector. Its flagship 100,000-ton erythritol project is a core component of its current industrial output.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 海化生命.